Sangamo Therapeutics (SGMOQ) Return on Capital Employed [ROCE] (2011 - 2025)
Sangamo Therapeutics' Return on Capital Employed [ROCE] came in at -382.12% for Q4 2025, down 210.68 percentage points from -171.44% a year earlier and down 128.43 percentage points from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Return on Capital Employed [ROCE] (2011 - 2025) Analysis & Trends
For FY2025, Sangamo Therapeutics' Return on Capital Employed [ROCE] was -317.18%, down 198.59 percentage points from FY2024.
- Return on Capital Employed [ROCE] has declined in each of the last six years, with a five-year change of -297.08 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -118.59% in FY2024 (-31.93 pp), -86.66% in FY2023 (-48.72 pp), -37.94% in FY2022 (-11.84 pp) and -26.10% in FY2021 (-6.00 pp).
- The Q4 2025 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
- Year-over-year, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -69.72 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2025 (a gain of 214.97 percentage points), and the weakest in Q2 2024 (a drop of 291.54 percentage points).
- Business Quant data shows SGMOQ's Return on Capital Employed [ROCE] at -253.69% (Q3 2025), -142.17% (Q2 2025) and -185.10% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Sangamo Therapeutics | 42.03 Mn | -72.08 Mn | - | -382.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -382.12% |
| Sep 30, 2025 | -253.69% |
| Jun 30, 2025 | -142.17% |
| Mar 31, 2025 | -185.10% |
| Dec 31, 2024 | -171.44% |
| Sep 30, 2024 | -237.44% |
| Jun 30, 2024 | -357.14% |
| Mar 31, 2024 | -321.39% |
| Dec 31, 2023 | -189.26% |
| Sep 30, 2023 | -119.40% |
| Jun 30, 2023 | -65.59% |
| Mar 31, 2023 | -31.10% |
| Dec 31, 2022 | -43.15% |
| Sep 30, 2022 | -38.45% |
| Jun 30, 2022 | -34.77% |
| Mar 31, 2022 | -32.00% |
| Dec 31, 2021 | -29.61% |
| Sep 30, 2021 | -27.81% |
| Jun 30, 2021 | -19.76% |
| Mar 31, 2021 | -16.95% |
API Access
Sangamo Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();